Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Bacteria directly initiate coagulation. Using microfluids, numerical simulations and mice, Kastrup et al. (p 742) provide an explanation for the correlation between bacterial infections and blood clotting. The authors found that localized clusters of some species of bacteria result in sufficient concentrations of endogenous factors, such as the zinc metalloprotease InhA1 in the case of Bacillus anthracis, to trigger the coagulation cascade directly (see also News and Views by Borenstein on p 718). A partial diagram of the hemostasis network is superimposed over the microfluids device used to investigate clotting. Cover art by Erin Boyle, based on images provided by Christian Kastrup and Helen Song.
Bacterial infections have long been associated with coagulation, but the mechanism is not well understood. New insights into bacterial spatial localization are shedding light on how bacterial clusters can trigger coagulation in a process known as 'quorum acting'.
The berberine bridge enzyme catalyzes the crucial step in the biosynthesis of an important class of alkaloids through a reaction that cannot be carried out using conventional organic chemistry tools. Characterization of the enzyme demonstrates a concerted mechanism that couples two distinct chemical steps—oxidation and proton abstraction—affecting two separate groups of the substrate.
Cell-surface carbohydrates are synthesized in a step-wise fashion, yielding products with unique capping structures. A recent study has shown that carbohydrates at the cell surface can be further remodeled by an endogenous glycosidase to alter the carbohydrate structure, thus generating a new function.
Small-molecule inhibitors of anti-apoptotic Bcl-2 proteins and BH3 mimetic peptides are promising anticancer agents. A recent study identifies a Nur77-based peptide that converts anti-apoptotic Bcl-2 proteins into pro-apoptotic molecules, providing another potential cancer therapeutic strategy.
Isoginkgetin has been identified as a general inhibitor of pre-mRNA splicing using an in vivo screening assay. This and related inhibitors will not only be useful as tools to decipher the roles of the individual components of the spliceosome but may also serve as therapeutics.
X-ray scattering from clusters of gold atoms provides a sensitive way of measuring long-range distance information in macromolecules and now reveals a surprisingly soft, stretchy character to double-stranded DNA.